MedPath

HEMOSATE ULTRA HS3150

HEMOSATE ULTRA HS3150

Approved
DIN Number

02413965

Drug Class

Human

Market Date

N/A

Company
HC

chief medical supplies ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02413965
AIG Number0752576008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormSolution
Route of AdministrationHaemodialysis
AHFS Classification40:34.00*
Health Canada Classification

ACTIVE INGREDIENTS (7)

CALCIUM CHLORIDEActive
Strength: 7.47 G / L
Monograph: CALCIUM CHLORIDE
CITRIC ACIDActive
Strength: 6.91 G / L
Monograph: CITRIC ACID
DEXTROSEActive
Strength: 49.5 G / L
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: 2.14 G / L
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 10.1 G / L
Monograph: POTASSIUM CHLORIDE
SODIUM ACETATEActive
Strength: 1.11 G / L
Monograph: SODIUM ACETATE
SODIUM CHLORIDEActive
Strength: 263 G / L
Monograph: SODIUM CHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.